Hepatitis B Reactivation Rate and Fate Among Multiple Myeloma Patients Receiving Regimens Containing Lenalidomide and/or Bortezomib

OBJECTIVE: Reactivation of the hepatitis B virus (HBV) refers to an increase in HBV replication in a patient with inactive or resolved HBV. In this retrospective study, our aim is to present and compare HBV reactivation in multiple myeloma (MM) patients who received lenalidomide and/or bortezomib at...

Descripción completa

Detalles Bibliográficos
Autores principales: Ataca Atilla, Pınar, Yalçıner, Merih, Atilla, Erden, İdilman, Ramazan, Beksaç, Meral
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Galenos Publishing 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863023/
https://www.ncbi.nlm.nih.gov/pubmed/31368290
http://dx.doi.org/10.4274/tjh.galenos.2019.2019.0103

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863023/
https://www.ncbi.nlm.nih.gov/pubmed/31368290
http://dx.doi.org/10.4274/tjh.galenos.2019.2019.0103

Ejemplares similares